Integrating Kaplan–Meier and LASSO Cox regression analyses, we defined a four-gene signature—UCK2, FABP5, CA9, and CYP2C9—that stratifies HCC patients into high- and low-risk groups with significant survival differences. This evidence concerns the gene FABP5 and hepatocellular carcinoma.